Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma.
OBJECTIVE
This study aimed to evaluate the causes of rhegmatogenous retinal detachment in children with retinoblastoma and to assess the surgical approach and results of retinal reattachment surgery.


METHODS
The study design was a retrospective review of all children in whom a rhegmatogenous retinal detachment developed after treatment for retinoblastoma over a 20-year period.


METHODS
Nine children, 5 to 33 months of age, participated.


METHODS
Assessment of the treatment methods for retinoblastoma, apparent cause of the rhegmatogenous retinal detachment, interval from the most recent retinoblastoma treatment until repair of the rhegmatogenous retinal detachment, method of surgical repair, and long-term anatomic and visual results were measured.


RESULTS
Rhegmatogenous retinal detachment was diagnosed in nine eyes of nine children with treated retinoblastoma. Prior treatment of retinoblastoma included cryotherapy (n = 5), laser photocoagulation (n = 1), external beam radiation therapy (n = 7), and systemic chemotherapy (n = 4). An atrophic retinal hole was present at the most recent site of cryotherapy in three eyes and of laser photocoagulation in one eye. Extreme retinal thinning with a possible retinal break was noted in two eyes at a cryotherapy site. A dialysis was noted in one eye, and a retinal break could not be detected in two eyes. Treatment of retinoblastoma tumors was performed between 1 week and 15 years before retinal reattachment surgery. The retinal detachment was repaired externally with a scleral buckling procedure in seven eyes, with subretinal fluid drainage in five eyes, and without drainage in two eyes. Cytologic evaluation of subretinal fluid was performed in three eyes and showed no tumor cells. The retinal detachment was repaired by pars plana vitrectomy in one eye, and the vitrectomy specimen showed no tumor cells. In one child, the retinal detachment was not repaired. The retina remained attached after surgery in five eyes with follow-up ranging from 5 to 115 months. In three eyes, retinal redetachment associated with recurrent viable intraocular retinoblastoma was noted after surgery, necessitating enucleation. In no case was orbital or metastatic retinoblastoma detected at follow-up.


CONCLUSIONS
Rhegmatogenous retinal detachment in children with treated retinoblastoma generally originates from an atrophic retinal hole at the site of prior cryotherapy or laser photocoagulation. If there appears to be complete regression of the intraocular tumor after treatment, surgical repair of the rhegmatogenous retinal detachment may be approached cautiously.
Baumal
C R
CR
Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.
Shields
C L
CL
Shields
J A
JA
Tasman
W S
WS
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003452:Cryosurgery / Q000009:adverse effects*; D004322:Drainage / Q000379:methods; D005260:Female; D006801:Humans; D007223:Infant; D017075:Laser Coagulation / Q000009:adverse effects*; D008297:Male; D012163:Retinal Detachment / Q000209:etiology / Q000601:surgery*; D019572:Retinal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D012167:Retinal Perforations / Q000209:etiology / Q000601:surgery; D012175:Retinoblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D012189:Retrospective Studies; D012591:Scleral Buckling; D014821:Vitrectomy
D000970:Antineoplastic Agents